PHARMERICA CORPORATION (NYSE: PMC) rated to Outperform with price target $38 by Barrington Research
Barrington Research rated PHARMERICA
CORPORATION (NYSE: PMC) to Outperform with price target $38.
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities and provides management pharmacy services to hospitals. It operates more than 100 institutional pharmacies in 40 states. The Company also provides pharmacy management services to 84 hospitals in the United States. The Company operates in two business segments: institutional pharmacies, which provides pharmacy services to nursing centers and other healthcare providers, and the hospital pharmacy management business, which provides management services to Kindred Healthcare, Inc.?s (Kindred) hospitals. On July 9, 2008, the Company purchased the 49% minority interest held by a third-party in its joint ventures. On November 1, 2008, the Company acquired an institutional pharmacy business providing medications, pharmacy and medical supplies and services to residents of skilled nursing homes.
As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in providing value to our clients. Our research provides us with a comprehensive understanding of the economy, financial markets, and individual companies, all of which are essential in recommending successful investments.